BFG
CVS icon

Berger Financial Group’s CVS Health CVS Stock Holding History

Berger Financial Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,468
Closed -$277K – 365
2024
Q1 		$277K Buy
3,468
+631
+22% +$48.2K 0.02% 292
2023
Q4 		$224K Sell
2,837
-735
-21% -$52.3K 0.02% 282
2023
Q3 		$249K Buy
3,572
+55
+2% +$3.9K 0.03% 238
2023
Q2 		$243K Sell
3,517
-34
-1% -$2.42K 0.03% 250
2023
Q1 		$264K Buy
3,551
+692
+24% +$58K 0.03% 224
2022
Q4 		$266K Buy
2,859
+104
+4% +$10K 0.04% 216
2022
Q3 		$263K Buy
2,755
+552
+25% +$54.6K 0.04% 201
2022
Q2 		$204K Sell
2,203
-130
-6% -$12.7K 0.03% 232
2022
Q1 		$236K Buy
2,333
+110
+5% +$11.6K 0.03% 244
2021
Q4 		$229K Buy
+2,223
New +$205K 0.03% 238
2021
Q1 		– Sell
-57,525
Closed -$3.93M – 197
2020
Q4 		$3.93M Buy
+57,525
New +$3.74M 0.69% 55

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Berger Financial Group's CVS Position: Q2 2024 in Review

Berger Financial Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,468 shares — an estimated $277K sold.

Berger Financial Group first reported a position in CVS in Q4 2020 and held it in 11 quarters. The position peaked at $3.93M in Q4 2020. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Berger Financial Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Berger Financial Group sold 3,468 CVS Health shares in Q2 2024, an estimated $277K.
  • Berger Financial Group first reported a position in CVS Health in Q4 2020 and held it in 11 quarters.
  • Berger Financial Group's CVS Health position peaked at $3.93M in Q4 2020.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Berger Financial Group's 13F filing for Q2 2024, filed 14 Aug 2024.